The present review gathers recent data demonstrating that orexins may have a therapeutic potential in several pathologies with an immune component including multiple sclerosis, Alzheimer's disease, narcolepsy, obesity, intestinal bowel diseases, septic shock, and cancers. The gene discussed is HCRT; the disease is obesity due to melanocortin 4 receptor deficiency.